SideROS

SideROS is a preclinical stage biotech company focused on accelerated development of innovative drug candidates for patients affected by high risk cancers

  • Stage Product In Development
  • Industry Biotechnology
  • Location Paris, France
  • Currency EUR
  • Founded January 2019
  • Employees 2
  • Incorporation Type Other
  • Website sideros.bio

Company Summary

Addressing patients worldwide diying of cancer due to resistance and relapse
after several therapeutic failure
• Expected number of deaths in 2040: 17 million (WHO source)
• Targeted therapies against persister cancer cells are needed
• Market size for targeted therapies in 2024 : $70 billion for all cancers

Team

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free